Uncovering Healthcare Profitability

Archive for November 2016

After DOJ denial, Mylan close to closing $465M settlement: 3 things to know

Even though Canonsburg, Pa.-based Mylan Pharmaceuticals agreed in October to pay $465 million to settle a U.S. Department of Justice investigation into EpiPen, the company is still working on finalizing the settlement, Fortune reports. Here’s what you need to know. 1. The U.S. Justice Department and other agencies have not confirmed the settlement. 2. Mylan […]

Read More